Literature DB >> 23015375

We still have a long way to go to effectively deliver genes!

Daniele Pezzoli1, Roberto Chiesa, Luigi De Nardo, Gabriele Candiani.   

Abstract

Gene therapy is emerging as a revolutionary alternative to conventional therapeutic approaches. However, its clinical application is still hampered by the lack of safe and effective gene delivery techniques. Among the plethora of diverse approaches used to ferry nucleic acids into target cells, non-viral vectors represent promising and safer alternatives to viruses and physical techniques. Both cationic lipids and polymers spontaneously wrap and shrink the genetic material in complexes named lipoplexes and polyplexes, respectively, thereby protecting it and shielding its negative charges. The development of non-viral vectors commenced more than two decades ago. Since then, some major classes of interesting molecules have been identified and modified to optimize their properties. However, the way towards the final goal of gene delivery, i.e. protein expression or gene silencing, is filled with obstacles and current non-viral carriers still have concerns about their overall efficiency. We strongly believe that the future of non-viral gene delivery relies on the development of multifunctional vectors specifically tailored with diverse functionalities that act more like viruses. Although these vectors are still a long way from clinical practice they are the ideal platform to effectively shuttle the genetic material to target cells in a safe and controlled way. In this review, after briefly introducing the basis of gene delivery and therapeutic applications we discuss the main polymeric and lipidic vectors utilized for gene delivery, focusing on the strategies adopted to overcome the major weaknesses inherent to their still limited activity, on the way towards ideal multifunctional vectors.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23015375     DOI: 10.5301/JABFM.2012.9707

Source DB:  PubMed          Journal:  J Appl Biomater Funct Mater        ISSN: 2280-8000            Impact factor:   2.604


  11 in total

1.  The roadmap to micro: Generation of micron-sized polymeric particles using a commercial microfluidic system.

Authors:  Melissa Cruz-Acuña; Hamilton Kakwere; Jamal S Lewis
Journal:  J Biomed Mater Res A       Date:  2022-01-24       Impact factor: 4.396

Review 2.  New progress in angiogenesis therapy of cardiovascular disease by ultrasound targeted microbubble destruction.

Authors:  Yang-Ying Liao; Zhi-Yi Chen; Yi-Xiang Wang; Yan Lin; Feng Yang; Qiu-Lan Zhou
Journal:  Biomed Res Int       Date:  2014-05-12       Impact factor: 3.411

3.  Cationic polyene phospholipids as DNA carriers for ocular gene therapy.

Authors:  Susana Machado; Sofia Calado; Diogo Bitoque; Ana Vanessa Oliveira; Christer L Øpstad; Muhammad Zeeshan; Hans-Richard Sliwka; Vassilia Partali; Michael D Pungente; Gabriela A Silva
Journal:  Biomed Res Int       Date:  2014-07-24       Impact factor: 3.411

4.  Promoter, transgene, and cell line effects in the transfection of mammalian cells using PDMAEMA-based nano-stars.

Authors:  Alexander Raup; Valérie Jérôme; Ruth Freitag; Christopher V Synatschke; Axel H E Müller
Journal:  Biotechnol Rep (Amst)       Date:  2016-06-16

5.  Size matters for in vitro gene delivery: investigating the relationships among complexation protocol, transfection medium, size and sedimentation.

Authors:  Daniele Pezzoli; Elisa Giupponi; Diego Mantovani; Gabriele Candiani
Journal:  Sci Rep       Date:  2017-03-08       Impact factor: 4.379

Review 6.  How will the field of gene therapy survive its success?

Authors:  William F Kaemmerer
Journal:  Bioeng Transl Med       Date:  2018-05-24

Review 7.  Genetic Delivery and Gene Therapy in Pulmonary Hypertension.

Authors:  Nabham Rai; Mazen Shihan; Werner Seeger; Ralph T Schermuly; Tatyana Novoyatleva
Journal:  Int J Mol Sci       Date:  2021-01-25       Impact factor: 5.923

8.  Improved alpharetrovirus-based Gag.MS2 particles for efficient and transient delivery of CRISPR-Cas9 into target cells.

Authors:  Yvonne Baron; Johanna Sens; Lucas Lange; Larissa Nassauer; Denise Klatt; Dirk Hoffmann; Marc-Jens Kleppa; Philippe Vollmer Barbosa; Maximilian Keisker; Viviane Steinberg; Julia D Suerth; Florian W R Vondran; Johann Meyer; Michael Morgan; Axel Schambach; Melanie Galla
Journal:  Mol Ther Nucleic Acids       Date:  2022-01-01       Impact factor: 8.886

9.  Delivery of miRNA-Targeted Oligonucleotides in the Rat Striatum by Magnetofection with Neuromag®.

Authors:  Simoneide Souza Titze de Almeida; Camila Hillesheim Horst; Cristina Soto-Sánchez; Eduardo Fernandez; Ricardo Titze de Almeida
Journal:  Molecules       Date:  2018-07-23       Impact factor: 4.411

Review 10.  Non-Viral in Vitro Gene Delivery: It is Now Time to Set the Bar!

Authors:  Nina Bono; Federica Ponti; Diego Mantovani; Gabriele Candiani
Journal:  Pharmaceutics       Date:  2020-02-21       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.